An update on drug–drug interactions with biologics for the treatment of moderate-to-severe psoriasis

Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies

(2013) Miroslav Dostalek et al.   CLINICAL PHARMACOKINETICS

Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data

(2012) M.H.A. Rustin   BRITISH JOURNAL OF DERMATOLOGY

Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

(2012) Rosa Parisi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Novel variants in the PRDX6 Gene and the risk of Acute Lung Injury following major trauma

(2011) Melanie Rushefski et al.   BMC Medical Genetics

Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis

(2011) David Ternant et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Disease–Drug–Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis

(2011) C Schmitt et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Influenza vaccination coverage among high-risk groups in 11 European countries

(2011) Adrian Loerbroks et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Changes in expression of hepatic cytochrome P450 subfamily enzymes during development of adjuvant-induced arthritis in rats

(2011) Hisakazu Sanada et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

The Effect of Infliximab on Hepatic Cytochrome P450 and Pharmacokinetics of Verapamil in Rats with Pre-Adjuvant Arthritis: A Drug-Disease and Drug-Drug Interaction

(2009) Spencer Ling et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics

(2009) ET Morgan   CLINICAL PHARMACOLOGY & THERAPEUTICS

Risk-based strategy for the assessment of pharmacokinetic drug–drug interactions for therapeutic monoclonal antibodies

(2009) Honghui Zhou et al.   DRUG DISCOVERY TODAY

Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis

(2009) Yaowei Zhu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

(2008) E. T. Morgan et al.   DRUG METABOLISM AND DISPOSITION

New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

(2008) Shiew-Mei Huang et al.   JOURNAL OF CLINICAL PHARMACOLOGY